DCK and urinary bladder cancer: Moreover, dCK activity was related to dCK mRNA levels in bladder cancer specimens as well as in tumour xenografts, and preliminary data in esophageal tumours demonstrated a significant correlation between dCK expression and response to gemcitabine-based treatment (Sigmond et al, 2004).